Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus

Virologica Sinica

Volumn 25, Issue 1, 2010, Pages 36-44

  Hou, Yu Xuan ^a   Peng, Cheng ^a   Han, Zheng Gang ^a   Zhou, Peng ^a   Chen, Ji Guo ^b   Shi, Zheng Li ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Cellular immune response; Humoral immune response; SARS coronavirus (SARS CoV); SARS like coronavirus (SL CoV); Spike glycoprotein

Indexed keywords

AMINO ACID; GAMMA INTERFERON; INTERLEUKIN 6; VIRUS SPIKE PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BAT; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; DRUG SCREENING; FEMALE; GENE SEQUENCE; GENE STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SARS CORONAVIRUS; SARS LIKE CORONAVIRUS; SPECIES DIFFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT; VIRUS ISOLATION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHIROPTERA; CROSS REACTIONS; FEMALE; GENE EXPRESSION; GENETIC VECTORS; HIV; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; SARS VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

ADENOVIRIDAE; CORONAVIRUS; MUS; RHINOLOPHUS; SARS CORONAVIRUS;

EID: 77249127132     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-010-3096-2     Document Type: Article

References (37)

1. B. Bai Q. Hu H. Hu, et al. 2008 Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells PLoS ONE 3 e2685 10.1371/journal.pone.0002685 18628832
2. R. S. Baric K. Fu M. C. Schaad, et al. 1990 Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups Virology 177 646 656 10.1016/0042-6822(90)90530-5 1:CAS:528:DyaK3cXltFSisbk%3D 2164728 (Pubitemid 20235186)
3. J. D. Berry S. Jones M. A. Drebot, et al. 2004 Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus J Virol Methods 120 87 96 10.1016/j.jviromet.2004.04.009 1:CAS:528: DC%2BD2cXltl2hurk%3D 15234813 (Pubitemid 38968659)
4. H. Bisht A. Roberts L. Vogel, et al. 2005 Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein Virology 334 160 165 10.1016/j.virol.2005.01.042 1:CAS:528:DC%2BD2MXisVCltLs%3D 15780866 (Pubitemid 40386951)
5. Z. Chen L. Zhang C. Qin, et al. 2005 Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region J Virol 79 2678 2688 10.1128/JVI.79.5.2678-2688.2005 1:CAS:528:DC%2BD2MXitlaqtbw%3D 15708987 (Pubitemid 40270546)
6. C. F. Chou S. Shen Y. J. Tan, et al. 2005 A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor J Virol Methods 123 41 48 10.1016/j.jviromet.2004.09.008 1:CAS:528:DC%2BD2cXhtVClt7vJ 15582697 (Pubitemid 39593732)
7. R. A. Fouchier T. Kuiken M. Schutten, et al. 2003 Aetiology: Koch's postulates fulfilled for SARS virus Nature 423 240 10.1038/423240a 1:CAS:528:DC%2BD3sXjs1yntb0%3D 12748632 (Pubitemid 40852688)
8. K. Fu R. S. Baric 1992 Evidence for variable rates of recombination in the MHV genome Virology 189 88 102 10.1016/0042-6822(92)90684-H 1:CAS:528:DyaK38XksVWrur8%3D 1318616
9. Y. Guan B. J. Zheng Y. Q. He, et al. 2003 Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China Science 302 276 278 10.1126/science.1087139 1:CAS:528:DC%2BD3sXnvFWgtL0%3D 12958366 (Pubitemid 37248756)
10. Y. He J. Li L. Du, et al. 2006 Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine Vaccine 24 5498 5508 10.1016/j.vaccine.2006.04.054 1:CAS:528: DC%2BD28Xls1Gqtb0%3D 16725238 (Pubitemid 43831381)
11. Y. He J. Li S. Heck, et al. 2006 Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design J Virol 80 5757 5767 10.1128/JVI.00083-06 1:CAS:528:DC%2BD28Xlslymtbo%3D 16731915 (Pubitemid 43849154)
12. Y. He J. Li S. Jiang 2006 A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity Biochem Biophys Res Commun 344 106 113 10.1016/j.bbrc.2006.03.139 1:CAS:528:DC%2BD28XjvFWns74%3D 16615996
13. Y. He H. Lu P. Siddiqui, et al. 2005 Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies J Immunol 174 4908 4915 1:CAS:528:DC%2BD2MXivFKiurc%3D 15814718
14. Y. He Y. Zhou S. Liu, et al. 2004 Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine Biochem Biophys Res Commun 324 773 781 10.1016/j.bbrc.2004.09.106 1:CAS:528:DC%2BD2cXotlCmsbo%3D 15474494 (Pubitemid 39345582)
15. Y. He Y. Zhou H. Wu, et al. 2004 Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines J Immunol 173 4050 4057 1:CAS:528:DC%2BD2cXnsVWktLY%3D 15356154
16. T. Y. Ho S. L. Wu S. E. Cheng, et al. 2004 Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein Biochem Biophys Res Commun 313 938 947 10.1016/j.bbrc.2003.11.180 1:CAS:528: DC%2BD2cXosFeq 14706633 (Pubitemid 38050083)
17. T. G. Ksiazek D. Erdman C. S. Goldsmith, et al. 2003 A novel coronavirus associated with severe acute respiratory syndrome N Engl J Med 348 1953 1966 10.1056/NEJMoa030781 1:CAS:528:DC%2BD3sXjslajtbk%3D 12690092 (Pubitemid 36569984)
18. S. K. Lau P. C. Woo K. S. Li, et al. 2005 Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats Proc Natl Acad Sci U S A 102 14040 14045 10.1073/pnas.0506735102 1:CAS:528:DC%2BD2MXhtVOqsbbO 16169905 (Pubitemid 41377699)
19. W. Li M. J. Moore N. Vasilieva, et al. 2003 Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 450 454 10.1038/nature02145 1:CAS:528:DC%2BD3sXpt1GlsLs%3D 14647384 (Pubitemid 37490132)
20. W. Li Z. Shi M. Yu, et al. 2005 Bats are natural reservoirs of SARS-like coronaviruses Science 310 676 679 10.1126/science.1118391 1:CAS:528: DC%2BD2MXhtFChsLjO 16195424 (Pubitemid 41528160)
21. R. Y. Liu L. Z. Wu B. J. Huang, et al. 2005 Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats Virus Res 112 24 31 10.1016/j.virusres.2005.02.009 1:CAS:528:DC%2BD2MXmt1SktLg%3D 16022898 (Pubitemid 40966771)
22. M. A. Marra S. J. Jones C. R. Astell, et al. 2003 The Genome sequence of the SARS-associated coronavirus Science 300 1399 1404 10.1126/science.1085953 1:CAS:528:DC%2BD3sXktFGkt7c%3D 12730501 (Pubitemid 36638153)
23. J. S. Peiris K. Y. Yuen A. D. Osterhaus, et al. 2003 The severe acute respiratory syndrome N Engl J Med 349 2431 2441 10.1056/NEJMra032498 1:CAS:528:DC%2BD3sXpvFGqurs%3D 14681510 (Pubitemid 37542993)
24. L. M. Pfeffer C. A. Dinarello R. B. Herberman, et al. 1998 Biological properties of recombinant alphainterferons: 40th anniversary of the discovery of interferons Cancer Res 58 2489 2499 1:CAS:528:DyaK1cXktVajtrY%3D 9635566
25. L. L. Poon D. K. Chu K. H. Chan, et al. 2005 Identification of a novel coronavirus in bats J Virol 79 2001 2009 10.1128/JVI.79.4.2001-2009.2005 1:CAS:528:DC%2BD2MXitlejtrc%3D 15681402 (Pubitemid 40204557)
26. W. Ren X. Qu W. Li, et al. 2008 Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin J Virol 82 1899 1907 10.1128/JVI.01085-07 1:CAS:528: DC%2BD1cXhvFartLg%3D 18077725 (Pubitemid 351206936)
27. P. A. Rota M. S. Oberste S. S. Monroe, et al. 2003 Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 1394 1399 10.1126/science.1085952 1:CAS:528:DC%2BD3sXktFGkt7Y%3D 12730500 (Pubitemid 36638152)
28. G. Simmons J. D. Reeves A. J. Rennekamp, et al. 2004 Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoproteinmediated viral entry Proc Natl Acad Sci USA 101 4240 4245 10.1073/pnas.0306446101 1:CAS:528:DC%2BD2cXivFartLw%3D 15010527 (Pubitemid 38405913)
29. U. Stroher A. DiCaro Y. Li, et al. 2004 Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha J Infect Dis 189 1164 1167 10.1086/382597 15031783 (Pubitemid 38457239)
30. X. C. Tang J. X. Zhang S. Y. Zhang, et al. 2006 Prevalence and genetic diversity of coronaviruses in bats from China J Virol 80 15 7481 7490 10.1128/JVI.00697-06 1:CAS:528:DC%2BD28XnsVWgtL8%3D 16840328 (Pubitemid 44092570)
31. W. Wang L. Ye L. Ye, et al. 2007 Up-regulation of IL-6 and TNF-alpha induced by SARS-coronavirus spike protein in murine macrophages via NF-kappaB pathway Virus Res 128 1 8 10.1016/j.virusres.2007.02.007 1:CAS:528: DC%2BD2sXovFKhurc%3D 17532082 (Pubitemid 47242878)
32. Y. D. Wang W. Y. Sin G. B. Xu, et al. 2004 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS J Virol 78 5612 5618 10.1128/JVI.78.11.5612-5618.2004 1:CAS:528:DC%2BD2cXksFCgs7g%3D 15140958 (Pubitemid 38661648)
33. P. C. Woo S. K. Lau K. S. Li, et al. 2006 Molecular diversity of coronaviruses in bats Virology 351 180 187 10.1016/j.virol.2006.02.041 1:CAS:528:DC%2BD28XntVyrtbY%3D 16647731 (Pubitemid 44037655)
34. Z. Y. Yang W. P. Kong Y. Huang, et al. 2004 A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice Nature 428 561 564 10.1038/nature02463 1:CAS:528:DC%2BD2cXis1GksL4%3D 15024391 (Pubitemid 38480539)
35. C. E. Yi L. Ba L. Zhang, et al. 2005 Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain J Virol 79 11638 11646 10.1128/JVI.79.18.11638-11646.2005 1:CAS:528:DC%2BD2MXhtVWkt7bL 16140741 (Pubitemid 41279282)
36. N. S. Zhong B. J. Zheng Y. M. Li, et al. 2003 Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February Lancet 362 1353 1358 10.1016/S0140-6736(03)14630-2 1:STN:280:DC%2BD3srhtVKgug%3D%3D 14585636 (Pubitemid 37338335)
37. Z. Zhou P. Post R. Chubet, et al. 2006 A recombinant baculovirus- expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice Vaccine 24 3624 3631 10.1016/j.vaccine.2006.01.059 1:CAS:528:DC%2BD28XjtFGksLg%3D 16497416